Nicole Cutler, L.Ac., MTCM, Dipl. Ac. (NCCAOM)® | Hepatitis Central - Part 17

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Nicole Cutler, L.Ac., MTCM, Dipl. Ac. (NCCAOM)®

Nicole Cutler, L.Ac., MTCM is a long time advocate of integrating perspectives on health. With a Bachelor’s degree in Neuroscience from the University of Rochester and a Master’s degree in Traditional Chinese Medicine from Five Branches Institute, Nicole has been a licensed acupuncturist since 2000. She has gathered acupuncture licenses in the states of California and New York, is a certified specialist with the National Acupuncture Detoxification Association, has earned diplomat status with the National Commission of Chinese and Oriental Medicine in Acupuncture and Chinese Herbology and is a member of the Society for Integrative Oncology. In addition to her acupuncture practice that focuses on stress and pain relief, digestion, immunity and oncology, Nicole contributes to the integration of healthcare by writing articles for professional massage therapists and people living with liver disease.

Here are my most recent posts:

Bulletin for Hep C Patients: Building on Dr. Oz's Advice

February 15, 2011 1 Comment

A recent, popular television show educated viewers on the importance of raising glutathione levels. Although the practical suggestions given were accurate, there is much more to know about this topic. Especially important for Hepatitis C patients, two supplements demonstrate unparalleled glutathione-boosting power.

Continue reading »

Hepatitis B May Resurface Postpartum

February 9, 2011

The changes in a woman's immune system during pregnancy can increase susceptibility to many pathogens, including a resurgence of latent ones. Research shows that even if a woman is just a carrier of Hepatitis B, liver issues can flare after she gives birth to a child.

Continue reading »

FDA Prioritizes Hepatitis C

December 28, 2010

In order for our society to overcome the burden of Hepatitis C, we must prioritize efforts to increase its awareness, detection and treatment. Moving along those lines, the FDA makes an important step in that direction.

Continue reading »